Profil
Magali Taiel is currently Chief Medical Officer at Gensight Biologics SA since 2019.
Formerly, Dr. Taiel was Vice President-Clinical Development at ProQR Therapeutics NV from 2016 to 2018 and Project Manager at Servier SAS from 1999 to 2001.
Dr. Taiel earned a doctorate from Universite Paris Cite in 1993.
Postes actifs de Magali Taiel
| Sociétés | Poste | Début |
|---|---|---|
| GENSIGHT BIOLOGICS S.A. | Directeur Technique/Scientifique/R&D | 08/10/2019 |
Anciens postes connus de Magali Taiel
| Sociétés | Poste | Fin |
|---|---|---|
| PROQR THERAPEUTICS N.V. | Corporate Officer/Principal | 01/09/2018 |
Servier SAS
Servier SAS Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Corporate Officer/Principal | 01/01/2001 |
Formation de Magali Taiel
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Gensight Biologics SA
Gensight Biologics SA Pharmaceuticals: MajorHealth Technology Manufactures and markets novel therapies for severe retinal neurodegenerative diseases | Health Technology |
ProQR Therapeutics NV
ProQR Therapeutics NV Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company with interest in the discovery and development of therapeutics for the treatment of genetic disorders | Health Technology |
Universite Paris Cite
Universite Paris Cite Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Servier SAS
Servier SAS Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
















